AVTX Archived Articles
Avalo Therapeutics (NASDAQ:AVTX): Advancing its Anti-IL-1β Candidate in Hidradenitis Suppurativa
Published on March 14, 2025
Avalo Therapeutics (AVTX): Unlocking the Potential of Immune Dysregulation
Published on November 30, 2024
Avalo Therapeutics, Inc. (NASDAQ:AVTX): Transforming Immune Dysregulation with a Promising Pipeline
Published on September 24, 2024